Search

Search bills, members, committees and pages...

Sign In

ALB SOLUTIONS

PreviousNext

148 federal lobbying filings, 2023 to 2026.

ALB SOLUTIONS is a registrant on 148 federal lobbying filings, 2023 to 2026, reporting $6M across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Clients

16 who it filed for, by filings.

ClientFilingsReported
BLUE CROSS AND BLUE SHIELD ASSOCIATION14$720K
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.14$560K
CAREVISO INC.14$280K
CVS HEALTH (AND SUBSIDIARIES)14$740K
ELEVANCE HEALTH, INC.14$840K
HUMANA, INC.14$600K
AMERICAN HEART ASSOCIATION13$550K
BETTER SOLUTIONS FOR HEALTHCARE13$600K
BLOOD CANCER UNITED9$290K
CENTENE CORPORATIONS7$180K
MARIUS PHARMACEUTICALS LLC7$170K
AIS HEALTHCARE3$80K
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATES3$100K
INDEPENDENCE BLUE CROSS3$80K
SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION3$60K
VERTEX PHARMACEUTICALS3$100K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
202635$1.4M—
202541$1.7M—
202439$1.6M—
202333$1.3M—

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues117
PHAPharmacy17
MMMMedicare/Medicaid14
MANManufacturing3
TARTariff (miscellaneous tariff bills)3
TRDTrade (domestic/foreign)3
TAXTaxation/Internal Revenue Code2

Lobbyists

Named on the filings.

LobbyistClientsFilings
ADAM BUCKALEW16148
VERONICA JACKSON1465

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
VERTEX PHARMACEUTICALSALB SOLUTIONS2026 second_quarter$50KJul 16, 2026
SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATIONALB SOLUTIONS2026 second_quarter$30KJul 16, 2026
INDEPENDENCE BLUE CROSSALB SOLUTIONS2026 second_quarter$40KJul 16, 2026
HUMANA, INC.ALB SOLUTIONS2026 second_quarter$60KJul 16, 2026
ELEVANCE HEALTH, INC.ALB SOLUTIONS2026 second_quarter$60KJul 16, 2026
CVS HEALTH (AND SUBSIDIARIES)ALB SOLUTIONS2026 second_quarter$70KJul 16, 2026
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATESALB SOLUTIONS2026 second_quarter$50KJul 16, 2026
CENTENE CORPORATIONSALB SOLUTIONS2026 second_quarter$30KJul 16, 2026
CAREVISO INC.ALB SOLUTIONS2026 second_quarter$20KJul 16, 2026
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.ALB SOLUTIONS2026 second_quarter$40KJul 16, 2026
BLUE CROSS AND BLUE SHIELD ASSOCIATIONALB SOLUTIONS2026 second_quarter$60KJul 16, 2026
BLOOD CANCER UNITEDALB SOLUTIONS2026 second_quarter$50KJul 16, 2026
BETTER SOLUTIONS FOR HEALTHCAREALB SOLUTIONS2026 second_quarter$50KJul 16, 2026
AMERICAN HEART ASSOCIATIONALB SOLUTIONS2026 second_quarter$50KJul 16, 2026
AIS HEALTHCAREALB SOLUTIONS2026 second_quarter$50KJul 16, 2026
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATESALB SOLUTIONS2026 first_quarter$50KApr 17, 2026
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATESALB SOLUTIONS2026 first_quarter—Apr 15, 2026
VERTEX PHARMACEUTICALSALB SOLUTIONS2026 first_quarter$50KApr 15, 2026
SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATIONALB SOLUTIONS2026 first_quarter$30KApr 15, 2026
INDEPENDENCE BLUE CROSSALB SOLUTIONS2026 first_quarter$40KApr 15, 2026
HUMANA, INC.ALB SOLUTIONS2026 first_quarter$60KApr 15, 2026
ELEVANCE HEALTH, INC.ALB SOLUTIONS2026 first_quarter$60KApr 15, 2026
CVS HEALTH (AND SUBSIDIARIES)ALB SOLUTIONS2026 first_quarter$70KApr 15, 2026
CENTENE CORPORATIONSALB SOLUTIONS2026 first_quarter$30KApr 15, 2026
CAREVISO INC.ALB SOLUTIONS2026 first_quarter$20KApr 15, 2026